REPORT ID 4110

Global T Cell Specific Surface Glycoprotein CD28 Sales Market Report 2017

Publish Date
15-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the global T Cell Specific Surface Glycoprotein CD28 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of T Cell Specific Surface Glycoprotein CD28 for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global T Cell Specific Surface Glycoprotein CD28 market competition by top manufacturers/players, with T Cell Specific Surface Glycoprotein CD28 sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Atox Bio Ltd
    Bristol-Myers Squibb Co
    Five Prime Therapeutics Inc
    Johnson & Johnson
    TheraMAB LLC
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    FPT-155
    FR-104
    Lulizumab Pegol
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Plaque Psoriasis
    Solid Tumor
    Acute Renal Failure(ARF)
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global T Cell Specific Surface Glycoprotein CD28 Sales Market Report 2017
1 T Cell Specific Surface Glycoprotein CD28 Market Overview
    1.1 Product Overview and Scope of T Cell Specific Surface Glycoprotein CD28
    1.2 Classification of T Cell Specific Surface Glycoprotein CD28 by Product Category
        1.2.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global T Cell Specific Surface Glycoprotein CD28 Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 FPT-155
        1.2.4 FR-104
        1.2.5 Lulizumab Pegol
        1.2.6 Others
    1.3 Global T Cell Specific Surface Glycoprotein CD28 Market by Application/End Users
        1.3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Plaque Psoriasis
        1.3.3 Solid Tumor
        1.3.4 Acute Renal Failure(ARF)
        1.3.5 Others
    1.4 Global T Cell Specific Surface Glycoprotein CD28 Market by Region
        1.4.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
        1.4.3 China T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
        1.4.4 Europe T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
        1.4.5 Japan T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
        1.4.6 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
        1.4.7 India T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of T Cell Specific Surface Glycoprotein CD28 (2012-2022)
        1.5.1 Global T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2012-2022)
        1.5.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2012-2022)

2 Global T Cell Specific Surface Glycoprotein CD28 Competition by Players/Suppliers, Type and Application
     2.1 Global T Cell Specific Surface Glycoprotein CD28 Market Competition by Players/Suppliers
        2.1.1 Global T Cell Specific Surface Glycoprotein CD28 Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global T Cell Specific Surface Glycoprotein CD28 (Volume and Value) by Type
        2.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Type (2012-2017)
        2.2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Type (2012-2017)
    2.3 Global T Cell Specific Surface Glycoprotein CD28 (Volume and Value) by Region
        2.3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Region (2012-2017)
        2.3.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Region (2012-2017)
    2.4 Global T Cell Specific Surface Glycoprotein CD28 (Volume) by Application

3 United States T Cell Specific Surface Glycoprotein CD28 (Volume, Value and Sales Price)
    3.1 United States T Cell Specific Surface Glycoprotein CD28 Sales and Value (2012-2017)
        3.1.1 United States T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2012-2017)
        3.1.2 United States T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2012-2017)
        3.1.3 United States T Cell Specific Surface Glycoprotein CD28 Sales Price Trend (2012-2017)
    3.2 United States T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Players
    3.3 United States T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Type
    3.4 United States T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Application

4 China T Cell Specific Surface Glycoprotein CD28 (Volume, Value and Sales Price)
    4.1 China T Cell Specific Surface Glycoprotein CD28 Sales and Value (2012-2017)
        4.1.1 China T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2012-2017)
        4.1.2 China T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2012-2017)
        4.1.3 China T Cell Specific Surface Glycoprotein CD28 Sales Price Trend (2012-2017)
    4.2 China T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Players
    4.3 China T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Type
    4.4 China T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Application

5 Europe T Cell Specific Surface Glycoprotein CD28 (Volume, Value and Sales Price)
    5.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales and Value (2012-2017)
        5.1.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2012-2017)
        5.1.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2012-2017)
        5.1.3 Europe T Cell Specific Surface Glycoprotein CD28 Sales Price Trend (2012-2017)
    5.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Players
    5.3 Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Type
    5.4 Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Application

6 Japan T Cell Specific Surface Glycoprotein CD28 (Volume, Value and Sales Price)
    6.1 Japan T Cell Specific Surface Glycoprotein CD28 Sales and Value (2012-2017)
        6.1.1 Japan T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2012-2017)
        6.1.2 Japan T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2012-2017)
        6.1.3 Japan T Cell Specific Surface Glycoprotein CD28 Sales Price Trend (2012-2017)
    6.2 Japan T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Players
    6.3 Japan T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Type
    6.4 Japan T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Application

7 Southeast Asia T Cell Specific Surface Glycoprotein CD28 (Volume, Value and Sales Price)
    7.1 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Sales and Value (2012-2017)
        7.1.1 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Sales Price Trend (2012-2017)
    7.2 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Players
    7.3 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Type
    7.4 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Application

8 India T Cell Specific Surface Glycoprotein CD28 (Volume, Value and Sales Price)
    8.1 India T Cell Specific Surface Glycoprotein CD28 Sales and Value (2012-2017)
        8.1.1 India T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2012-2017)
        8.1.2 India T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2012-2017)
        8.1.3 India T Cell Specific Surface Glycoprotein CD28 Sales Price Trend (2012-2017)
    8.2 India T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Players
    8.3 India T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Type
    8.4 India T Cell Specific Surface Glycoprotein CD28 Sales Volume and Market Share by Application

9 Global T Cell Specific Surface Glycoprotein CD28 Players/Suppliers Profiles and Sales Data
    9.1 Atox Bio Ltd
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Bristol-Myers Squibb Co
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Five Prime Therapeutics Inc
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Johnson & Johnson
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 TheraMAB LLC
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    ...

10 T Cell Specific Surface Glycoprotein CD28 Maufacturing Cost Analysis
    10.1 T Cell Specific Surface Glycoprotein CD28 Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
    10.3 Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 T Cell Specific Surface Glycoprotein CD28 Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of T Cell Specific Surface Glycoprotein CD28 Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global T Cell Specific Surface Glycoprotein CD28 Market Forecast (2017-2022)
    14.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global T Cell Specific Surface Glycoprotein CD28 Price and Trend Forecast (2017-2022)
    14.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Type (2017-2022)
       14.3.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Type (2017-2022)
       14.3.3 Global T Cell Specific Surface Glycoprotein CD28 Price Forecast by Type (2017-2022)
    14.4 Global T Cell Specific Surface Glycoprotein CD28 Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer